1 Study Coverage 1.1 Rifampin Product Introduction 1.2 Market by Type 1.2.1 Global Rifampin Market Size Growth Rate by Type 1.4.2 Capsule 1.4.3 Injection 1.2.4 Eye Drop 1.3 Market by Application 1.3.1 Global Rifampin Market Size Growth Rate by Application 1.3.2 Tuberculosis 1.3.3 Leprosy 1.3.4 Legionnaire's Disease 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Rifampin Sales Estimates and Forecasts 2016-2027 2.2 Global Rifampin Revenue Estimates and Forecasts 2016-2027 2.3 Global Rifampin Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Rifampin Regions by Sales 2.4.1 Global Top Rifampin Regions by Sales (2016-2021) 2.4.2 Global Top Rifampin Regions by Sales (2022-2027) 2.5 Global Top Rifampin Regions by Revenue 2.5.1 Global Top Rifampin Regions by Revenue (2016-2021) 2.5.2 Global Top Rifampin Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Rifampin Sales by Manufacturers 3.1.1 Global Top Rifampin Manufacturers by Sales (2016-2021) 3.1.2 Global Top Rifampin Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Rifampin Sales in 2020 3.2 Global Rifampin Revenue by Manufacturers 3.2.1 Global Top Rifampin Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Rifampin Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Rifampin Revenue in 2020 3.3 Global Rifampin Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Rifampin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Rifampin Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Rifampin Sales by Type 4.1.1 Global Rifampin Historical Sales by Type (2016-2021) 4.1.2 Global Rifampin Forecasted Sales by Type (2022-2027) 4.1.3 Global Rifampin Sales Market Share by Type (2016-2027) 4.2 Global Rifampin Revenue by Type 4.2.1 Global Rifampin Historical Revenue by Type (2016-2021) 4.2.2 Global Rifampin Forecasted Revenue by Type (2022-2027) 4.2.3 Global Rifampin Revenue Market Share by Type (2016-2027) 4.3 Global Rifampin Price by Type 4.3.1 Global Rifampin Price by Type (2016-2021) 4.3.2 Global Rifampin Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Rifampin Sales by Application 5.1.1 Global Rifampin Historical Sales by Application (2016-2021) 5.1.2 Global Rifampin Forecasted Sales by Application (2022-2027) 5.1.3 Global Rifampin Sales Market Share by Application (2016-2027) 5.2 Global Rifampin Revenue by Application 5.2.1 Global Rifampin Historical Revenue by Application (2016-2021) 5.2.2 Global Rifampin Forecasted Revenue by Application (2022-2027) 5.2.3 Global Rifampin Revenue Market Share by Application (2016-2027) 5.3 Global Rifampin Price by Application 5.3.1 Global Rifampin Price by Application (2016-2021) 5.3.2 Global Rifampin Price Forecast by Application (2022-2027) 6 North America 6.1 North America Rifampin Market Size by Type 6.1.1 North America Rifampin Sales by Type (2016-2027) 6.1.2 North America Rifampin Revenue by Type (2016-2027) 6.2 North America Rifampin Market Size by Application 6.2.1 North America Rifampin Sales by Application (2016-2027) 6.2.2 North America Rifampin Revenue by Application (2016-2027) 6.3 North America Rifampin Market Size by Country 6.3.1 North America Rifampin Sales by Country (2016-2027) 6.3.2 North America Rifampin Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Rifampin Market Size by Type 7.1.1 Europe Rifampin Sales by Type (2017-2027) 7.1.2 Europe Rifampin Revenue by Type (2017-2027) 7.2 Europe Rifampin Market Size by Application 7.2.1 Europe Rifampin Sales by Application (2017-2027) 7.2.2 Europe Rifampin Revenue by Application (2017-2027) 7.3 Europe Rifampin Market Size by Country 7.3.1 Europe Rifampin Sales by Country (2017-2027) 7.3.2 Europe Rifampin Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Rifampin Market Size by Type 8.1.1 Asia Pacific Rifampin Sales by Type (2018-2027) 8.1.2 Asia Pacific Rifampin Revenue by Type (2018-2027) 8.2 Asia Pacific Rifampin Market Size by Application 8.2.1 Asia Pacific Rifampin Sales by Application (2018-2027) 8.2.2 Asia Pacific Rifampin Revenue by Application (2018-2027) 8.3 Asia Pacific Rifampin Market Size by Region 8.3.1 Asia Pacific Rifampin Sales by Region (2018-2027) 8.3.2 Asia Pacific Rifampin Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Rifampin Market Size by Type 9.1.1 Latin America Rifampin Sales by Type (2019-2027) 9.1.2 Latin America Rifampin Revenue by Type (2019-2027) 9.2 Latin America Rifampin Market Size by Application 9.2.1 Latin America Rifampin Sales by Application (2019-2027) 9.2.2 Latin America Rifampin Revenue by Application (2019-2027) 9.3 Latin America Rifampin Market Size by Country 9.3.1 Latin America Rifampin Sales by Country (2019-2027) 9.3.2 Latin America Rifampin Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Rifampin Market Size by Type 6.1.1 Middle East and Africa Rifampin Sales by Type (2016-2027) 6.1.2 Middle East and Africa Rifampin Revenue by Type (2016-2027) 6.2 Middle East and Africa Rifampin Market Size by Application 6.2.1 Middle East and Africa Rifampin Sales by Application (2016-2027) 6.2.2 Middle East and Africa Rifampin Revenue by Application (2016-2027) 6.3 Middle East and Africa Rifampin Market Size by Country 6.3.1 Middle East and Africa Rifampin Sales by Country (2016-2027) 6.3.2 Middle East and Africa Rifampin Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Corporation Information 11.1.2 Sanofi Overview 11.1.3 Sanofi Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Sanofi Rifampin Product Description 11.1.5 Sanofi Related Developments 11.2 Wellona Pharma 11.2.1 Wellona Pharma Corporation Information 11.2.2 Wellona Pharma Overview 11.2.3 Wellona Pharma Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Wellona Pharma Rifampin Product Description 11.2.5 Wellona Pharma Related Developments 11.3 Mylan 11.3.1 Mylan Corporation Information 11.3.2 Mylan Overview 11.3.3 Mylan Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Mylan Rifampin Product Description 11.3.5 Mylan Related Developments 11.4 Shenyang Tonglian Group 11.4.1 Shenyang Tonglian Group Corporation Information 11.4.2 Shenyang Tonglian Group Overview 11.4.3 Shenyang Tonglian Group Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Shenyang Tonglian Group Rifampin Product Description 11.4.5 Shenyang Tonglian Group Related Developments 11.5 Fresenius Kabi 11.5.1 Fresenius Kabi Corporation Information 11.5.2 Fresenius Kabi Overview 11.5.3 Fresenius Kabi Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Fresenius Kabi Rifampin Product Description 11.5.5 Fresenius Kabi Related Developments 11.6 Avet Pharmaceuticals Inc. 11.6.1 Avet Pharmaceuticals Inc. Corporation Information 11.6.2 Avet Pharmaceuticals Inc. Overview 11.6.3 Avet Pharmaceuticals Inc. Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Avet Pharmaceuticals Inc. Rifampin Product Description 11.6.5 Avet Pharmaceuticals Inc. Related Developments 11.7 Lannett Company 11.7.1 Lannett Company Corporation Information 11.7.2 Lannett Company Overview 11.7.3 Lannett Company Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Lannett Company Rifampin Product Description 11.7.5 Lannett Company Related Developments 11.8 Lupin Pharmaceutica 11.8.1 Lupin Pharmaceutica Corporation Information 11.8.2 Lupin Pharmaceutica Overview 11.8.3 Lupin Pharmaceutica Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Lupin Pharmaceutica Rifampin Product Description 11.8.5 Lupin Pharmaceutica Related Developments 11.9 Hikma 11.9.1 Hikma Corporation Information 11.9.2 Hikma Overview 11.9.3 Hikma Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Hikma Rifampin Product Description 11.9.5 Hikma Related Developments 11.10 Shuangding Pharm 11.10.1 Shuangding Pharm Corporation Information 11.10.2 Shuangding Pharm Overview 11.10.3 Shuangding Pharm Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Shuangding Pharm Rifampin Product Description 11.10.5 Shuangding Pharm Related Developments 11.1 Sanofi 11.1.1 Sanofi Corporation Information 11.1.2 Sanofi Overview 11.1.3 Sanofi Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Sanofi Rifampin Product Description 11.1.5 Sanofi Related Developments 11.12 Jiangsu Puhua Kesheng 11.12.1 Jiangsu Puhua Kesheng Corporation Information 11.12.2 Jiangsu Puhua Kesheng Overview 11.12.3 Jiangsu Puhua Kesheng Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 Jiangsu Puhua Kesheng Product Description 11.12.5 Jiangsu Puhua Kesheng Related Developments 11.13 Chengdu Jinhua (Hongyun) 11.13.1 Chengdu Jinhua (Hongyun) Corporation Information 11.13.2 Chengdu Jinhua (Hongyun) Overview 11.13.3 Chengdu Jinhua (Hongyun) Rifampin Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 Chengdu Jinhua (Hongyun) Product Description 11.13.5 Chengdu Jinhua (Hongyun) Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Rifampin Value Chain Analysis 12.2 Rifampin Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Rifampin Production Mode & Process 12.4 Rifampin Sales and Marketing 12.4.1 Rifampin Sales Channels 12.4.2 Rifampin Distributors 12.5 Rifampin Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Rifampin Industry Trends 13.2 Rifampin Market Drivers 13.3 Rifampin Market Challenges 13.4 Rifampin Market Restraints 14 Key Findings in The Global Rifampin Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Rifampin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Capsule Table 3. Major Manufacturers of Injection Table 4. Major Manufacturers of Eye Drop Table 5. Global Rifampin Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Rifampin Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Rifampin Sales by Region (2016-2021) & (K MT) Table 8. Global Rifampin Sales Market Share by Region (2016-2021) Table 9. Global Rifampin Sales by Region (2016-2021) & (K MT) Table 10. Global Rifampin Sales Market Share by Region (2022-2027) Table 11. Global Rifampin Revenue by Region (2016-2021) & (US$ Million) Table 12. Global Rifampin Revenue Market Share by Region (2016-2021) Table 13. Global Rifampin Revenue by Region (2022-2027) & (US$ Million) Table 14. Global Rifampin Revenue Market Share by Region (2022-2027) Table 15. Global Rifampin Sales by Manufacturers (2016-2021) & (K MT) Table 16. Global Rifampin Sales Share by Manufacturers (2016-2021) Table 17. Global Rifampin Revenue by Manufacturers (2016-2021) & (US$ Million) Table 18. Global Rifampin Revenue Share by Manufacturers (2016-2021) Table 19. Rifampin Price by Manufacturers 2016-2021 (USD/MT) Table 20. Global Rifampin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Rifampin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifampin as of 2020) Table 22. Rifampin Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Rifampin Product Offered Table 24. Date of Manufacturers Enter into Rifampin Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Rifampin Sales by Type (2016-2021) & (K MT) Table 27. Global Rifampin Sales by Type (2022-2027) & (K MT) Table 28. Global Rifampin Sales Share by Type (2016-2021) Table 29. Global Rifampin Sales Share by Type (2022-2027) Table 30. Global Rifampin Revenue by Type (2016-2021) & (US$ Million) Table 31. Global Rifampin Revenue by Type (2022-2027) & (US$ Million) Table 32. Global Rifampin Revenue Share by Type (2016-2021) Table 33. Global Rifampin Revenue Share by Type (2022-2027) Table 34. Rifampin Price by Type (2016-2021) & (USD/MT) Table 35. Global Rifampin Price Forecast by Type (2022-2027) & (USD/MT) Table 36. Global Rifampin Sales by Application (2016-2021) & (K MT) Table 37. Global Rifampin Sales by Application (2022-2027) & (K MT) Table 38. Global Rifampin Sales Share by Application (2016-2021) Table 39. Global Rifampin Sales Share by Application (2022-2027) Table 40. Global Rifampin Revenue by Application (2016-2021) & (US$ Million) Table 41. Global Rifampin Revenue by Application (2022-2027) & (US$ Million) Table 42. Global Rifampin Revenue Share by Application (2016-2021) Table 43. Global Rifampin Revenue Share by Application (2022-2027) Table 44. Rifampin Price by Application (2016-2021) & (USD/MT) Table 45. Global Rifampin Price Forecast by Application (2022-2027) & (USD/MT) Table 46. North America Rifampin Sales by Type (2016-2021) & (K MT) Table 47. North America Rifampin Sales by Type (2022-2027) & (K MT) Table 48. North America Rifampin Revenue by Type (2016-2021) & (US$ Million) Table 49. North America Rifampin Revenue by Type (2022-2027) & (US$ Million) Table 50. North America Rifampin Sales by Application (2016-2021) & (K MT) Table 51. North America Rifampin Sales by Application (2022-2027) & (K MT) Table 52. North America Rifampin Revenue by Application (2016-2021) & (US$ Million) Table 53. North America Rifampin Revenue by Application (2022-2027) & (US$ Million) Table 54. North America Rifampin Sales by Country (2016-2021) & (K MT) Table 55. North America Rifampin Sales by Country (2022-2027) & (K MT) Table 56. North America Rifampin Revenue by Country (2016-2021) & (US$ Million) Table 57. North America Rifampin Revenue by Country (2022-2027) & (US$ Million) Table 58. Europe Rifampin Sales by Type (2016-2021) & (K MT) Table 59. Europe Rifampin Sales by Type (2022-2027) & (K MT) Table 60. Europe Rifampin Revenue by Type (2016-2021) & (US$ Million) Table 61. Europe Rifampin Revenue by Type (2022-2027) & (US$ Million) Table 62. Europe Rifampin Sales by Application (2016-2021) & (K MT) Table 63. Europe Rifampin Sales by Application (2022-2027) & (K MT) Table 64. Europe Rifampin Revenue by Application (2016-2021) & (US$ Million) Table 65. Europe Rifampin Revenue by Application (2022-2027) & (US$ Million) Table 66. Europe Rifampin Sales by Country (2016-2021) & (K MT) Table 67. Europe Rifampin Sales by Country (2022-2027) & (K MT) Table 68. Europe Rifampin Revenue by Country (2016-2021) & (US$ Million) Table 69. Europe Rifampin Revenue by Country (2022-2027) & (US$ Million) Table 70. Asia Pacific Rifampin Sales by Type (2016-2021) & (K MT) Table 71. Asia Pacific Rifampin Sales by Type (2022-2027) & (K MT) Table 72. Asia Pacific Rifampin Revenue by Type (2016-2021) & (US$ Million) Table 73. Asia Pacific Rifampin Revenue by Type (2022-2027) & (US$ Million) Table 74. Asia Pacific Rifampin Sales by Application (2016-2021) & (K MT) Table 75. Asia Pacific Rifampin Sales by Application (2022-2027) & (K MT) Table 76. Asia Pacific Rifampin Revenue by Application (2016-2021) & (US$ Million) Table 77. Asia Pacific Rifampin Revenue by Application (2022-2027) & (US$ Million) Table 78. Asia Pacific Rifampin Sales by Region (2016-2021) & (K MT) Table 79. Asia Pacific Rifampin Sales by Region (2022-2027) & (K MT) Table 80. Asia Pacific Rifampin Revenue by Region (2016-2021) & (US$ Million) Table 81. Asia Pacific Rifampin Revenue by Region (2022-2027) & (US$ Million) Table 82. Latin America Rifampin Sales by Type (2016-2021) & (K MT) Table 83. Latin America Rifampin Sales by Type (2022-2027) & (K MT) Table 84. Latin America Rifampin Revenue by Type (2016-2021) & (US$ Million) Table 85. Latin America Rifampin Revenue by Type (2022-2027) & (US$ Million) Table 86. Latin America Rifampin Sales by Application (2016-2021) & (K MT) Table 87. Latin America Rifampin Sales by Application (2022-2027) & (K MT) Table 88. Latin America Rifampin Revenue by Application (2016-2021) & (US$ Million) Table 89. Latin America Rifampin Revenue by Application (2022-2027) & (US$ Million) Table 90. Latin America Rifampin Sales by Country (2016-2021) & (K MT) Table 91. Latin America Rifampin Sales by Country (2022-2027) & (K MT) Table 92. Latin America Rifampin Revenue by Country (2016-2021) & (US$ Million) Table 93. Latin America Rifampin Revenue by Country (2022-2027) & (US$ Million) Table 94. Middle East and Africa Rifampin Sales by Type (2016-2021) & (K MT) Table 95. Middle East and Africa Rifampin Sales by Type (2022-2027) & (K MT) Table 96. Middle East and Africa Rifampin Revenue by Type (2016-2021) & (US$ Million) Table 97. Middle East and Africa Rifampin Revenue by Type (2022-2027) & (US$ Million) Table 98. Middle East and Africa Rifampin Sales by Application (2016-2021) & (K MT) Table 99. Middle East and Africa Rifampin Sales by Application (2022-2027) & (K MT) Table 100. Middle East and Africa Rifampin Revenue by Application (2016-2021) & (US$ Million) Table 101. Middle East and Africa Rifampin Revenue by Application (2022-2027) & (US$ Million) Table 102. Middle East and Africa Rifampin Sales by Country (2016-2021) & (K MT) Table 103. Middle East and Africa Rifampin Sales by Country (2022-2027) & (K MT) Table 104. Middle East and Africa Rifampin Revenue by Country (2016-2021) & (US$ Million) Table 105. Middle East and Africa Rifampin Revenue by Country (2022-2027) & (US$ Million) Table 106. Sanofi Corporation Information Table 107. Sanofi Description and Major Businesses Table 108. Sanofi Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 109. Sanofi Rifampin Product Table 110. Sanofi Recent Developments Table 111. Wellona Pharma Corporation Information Table 112. Wellona Pharma Description and Major Businesses Table 113. Wellona Pharma Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 114. Wellona Pharma Rifampin Product Table 115. Wellona Pharma Recent Developments Table 116. Mylan Corporation Information Table 117. Mylan Description and Major Businesses Table 118. Mylan Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 119. Mylan Rifampin Product Table 120. Mylan Recent Developments Table 121. Shenyang Tonglian Group Corporation Information Table 122. Shenyang Tonglian Group Description and Major Businesses Table 123. Shenyang Tonglian Group Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 124. Shenyang Tonglian Group Rifampin Product Table 125. Shenyang Tonglian Group Recent Developments Table 126. Fresenius Kabi Corporation Information Table 127. Fresenius Kabi Description and Major Businesses Table 128. Fresenius Kabi Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 129. Fresenius Kabi Rifampin Product Table 130. Fresenius Kabi Recent Developments Table 131. Avet Pharmaceuticals Inc. Corporation Information Table 132. Avet Pharmaceuticals Inc. Description and Major Businesses Table 133. Avet Pharmaceuticals Inc. Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 134. Avet Pharmaceuticals Inc. Rifampin Product Table 135. Avet Pharmaceuticals Inc. Recent Developments Table 136. Lannett Company Corporation Information Table 137. Lannett Company Description and Major Businesses Table 138. Lannett Company Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 139. Lannett Company Rifampin Product Table 140. Lannett Company Recent Developments Table 141. Lupin Pharmaceutica Corporation Information Table 142. Lupin Pharmaceutica Description and Major Businesses Table 143. Lupin Pharmaceutica Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 144. Lupin Pharmaceutica Rifampin Product Table 145. Lupin Pharmaceutica Recent Developments Table 146. Hikma Corporation Information Table 147. Hikma Description and Major Businesses Table 148. Hikma Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 149. Hikma Rifampin Product Table 150. Hikma Recent Developments Table 151. Shuangding Pharm Corporation Information Table 152. Shuangding Pharm Description and Major Businesses Table 153. Shuangding Pharm Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 154. Shuangding Pharm Rifampin Product Table 155. Shuangding Pharm Recent Developments Table 156. Wuhan Wujing Corporation Information Table 157. Wuhan Wujing Description and Major Businesses Table 158. Wuhan Wujing Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 159. Wuhan Wujing Rifampin Product Table 160. Wuhan Wujing Recent Developments Table 161. Jiangsu Puhua Kesheng Corporation Information Table 162. Jiangsu Puhua Kesheng Description and Major Businesses Table 163. Jiangsu Puhua Kesheng Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 164. Jiangsu Puhua Kesheng Rifampin Product Table 165. Jiangsu Puhua Kesheng Recent Developments Table 166. Chengdu Jinhua (Hongyun) Corporation Information Table 167. Chengdu Jinhua (Hongyun) Description and Major Businesses Table 168. Chengdu Jinhua (Hongyun) Rifampin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 169. Chengdu Jinhua (Hongyun) Rifampin Product Table 170. Chengdu Jinhua (Hongyun) Recent Developments Table 171. Key Raw Materials Lists Table 172. Raw Materials Key Suppliers Lists Table 173. Rifampin Distributors List Table 174. Rifampin Customers List Table 175. Rifampin Market Trends Table 176. Rifampin Market Drivers Table 177. Rifampin Market Challenges Table 178. Rifampin Market Restraints Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Rifampin Product Picture Figure 2. Global Rifampin Market Share by Type in 2020 & 2027 Figure 3. Capsule Product Picture Figure 4. Injection Product Picture Figure 5. Eye Drop Product Picture Figure 6. Global Rifampin Sales Market Share by Application in 2020 & 2027 Figure 7. Tuberculosis Figure 8. Leprosy Figure 9. Legionnaire's Disease Figure 10. Others Figure 11. Rifampin Report Years Considered Figure 12. Global Rifampin Sales 2016-2027 (K MT) Figure 13. Global Rifampin Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Rifampin Revenue 2016-2027 (US$ Million) Figure 15. Global Rifampin Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 16. Global Rifampin Sales Market Share by Region (2016-2021) Figure 17. Global Rifampin Sales Market Share by Region (2022-2027) Figure 18. North America Rifampin Sales YoY (2016-2027) & (K MT) Figure 19. North America Rifampin Revenue YoY (2016-2027) & (US$ Million) Figure 20. Europe Rifampin Sales YoY (2016-2027) & (K MT) Figure 21. Europe Rifampin Revenue YoY (2016-2027) & (US$ Million) Figure 22. Asia-Pacific Rifampin Sales YoY (2016-2027) & (K MT) Figure 23. Asia-Pacific Rifampin Revenue YoY (2016-2027) & (US$ Million) Figure 24. Latin America Rifampin Sales YoY (2016-2027) & (K MT) Figure 25. Latin America Rifampin Revenue YoY (2016-2027) & (US$ Million) Figure 26. Middle East & Africa Rifampin Sales YoY (2016-2027) & (K MT) Figure 27. Middle East & Africa Rifampin Revenue YoY (2016-2027) & (US$ Million) Figure 28. The Top 10 and Top 5 Players Market Share by Rifampin Sales in 2020 Figure 29. The Top 10 and Top 5 Players Market Share by Rifampin Revenue in 2020 Figure 30. Rifampin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 31. Global Rifampin Sales Market Share by Type (2016-2027) Figure 32. Global Rifampin Revenue Market Share by Type (2016-2027) Figure 33. Global Rifampin Sales Market Share by Application (2016-2027) Figure 34. Global Rifampin Revenue Market Share by Application (2016-2027) Figure 35. North America Rifampin Sales Market Share by Type (2016-2027) Figure 36. North America Rifampin Revenue Market Share by Type (2016-2027) Figure 37. North America Rifampin Sales Market Share by Application (2016-2027) Figure 38. North America Rifampin Revenue Market Share by Application (2016-2027) Figure 39. North America Rifampin Sales Share by Country (2016-2027) Figure 40. North America Rifampin Revenue Share by Country (2016-2027) Figure 41. U.S. Rifampin Revenue (2016-2027) & (US$ Million) Figure 42. Canada Rifampin Revenue (2016-2027) & (US$ Million) Figure 43. Europe Rifampin Sales Market Share by Type (2016-2027) Figure 44. Europe Rifampin Revenue Market Share by Type (2016-2027) Figure 45. Europe Rifampin Sales Market Share by Application (2016-2027) Figure 46. Europe Rifampin Revenue Market Share by Application (2016-2027) Figure 47. Europe Rifampin Sales Share by Country (2016-2027) Figure 48. Europe Rifampin Revenue Share by Country (2016-2027) Figure 49. Germany Rifampin Revenue (2016-2027) & (US$ Million) Figure 50. France Rifampin Revenue (2016-2027) & (US$ Million) Figure 51. U.K. Rifampin Revenue (2016-2027) & (US$ Million) Figure 52. Italy Rifampin Revenue (2016-2027) & (US$ Million) Figure 53. Russia Rifampin Revenue (2016-2027) & (US$ Million) Figure 54. Asia Pacific Rifampin Sales Market Share by Type (2016-2027) Figure 55. Asia Pacific Rifampin Revenue Market Share by Type (2016-2027) Figure 56. Asia Pacific Rifampin Sales Market Share by Application (2016-2027) Figure 57. Asia Pacific Rifampin Revenue Market Share by Application (2016-2027) Figure 58. Asia Pacific Rifampin Sales Share by Region (2016-2027) Figure 59. Asia Pacific Rifampin Revenue Share by Region (2016-2027) Figure 60. China Rifampin Revenue (2016-2027) & (US$ Million) Figure 61. Japan Rifampin Revenue (2016-2027) & (US$ Million) Figure 62. South Korea Rifampin Revenue (2016-2027) & (US$ Million) Figure 63. India Rifampin Revenue (2016-2027) & (US$ Million) Figure 64. Australia Rifampin Revenue (2016-2027) & (US$ Million) Figure 65. Taiwan Rifampin Revenue (2016-2027) & (US$ Million) Figure 66. Indonesia Rifampin Revenue (2016-2027) & (US$ Million) Figure 67. Thailand Rifampin Revenue (2016-2027) & (US$ Million) Figure 68. Malaysia Rifampin Revenue (2016-2027) & (US$ Million) Figure 69. Philippines Rifampin Revenue (2016-2027) & (US$ Million) Figure 70. Latin America Rifampin Sales Market Share by Type (2016-2027) Figure 71. Latin America Rifampin Revenue Market Share by Type (2016-2027) Figure 72. Latin America Rifampin Sales Market Share by Application (2016-2027) Figure 73. Latin America Rifampin Revenue Market Share by Application (2016-2027) Figure 74. Latin America Rifampin Sales Share by Country (2016-2027) Figure 75. Latin America Rifampin Revenue Share by Country (2016-2027) Figure 76. Mexico Rifampin Revenue (2016-2027) & (US$ Million) Figure 77. Brazil Rifampin Revenue (2016-2027) & (US$ Million) Figure 78. Argentina Rifampin Revenue (2016-2027) & (US$ Million) Figure 79. Middle East and Africa Rifampin Sales Market Share by Type (2016-2027) Figure 80. Middle East and Africa Rifampin Revenue Market Share by Type (2016-2027) Figure 81. Middle East and Africa Rifampin Sales Market Share by Application (2016-2027) Figure 82. Middle East and Africa Rifampin Revenue Market Share by Application (2016-2027) Figure 83. Middle East and Africa Rifampin Sales Share by Country (2016-2027) Figure 84. Middle East and Africa Rifampin Revenue Share by Country (2016-2027) Figure 85. Turkey Rifampin Revenue (2016-2027) & (US$ Million) Figure 86. Saudi Arabia Rifampin Revenue (2016-2027) & (US$ Million) Figure 87. U.A.E Rifampin Revenue (2016-2027) & (US$ Million) Figure 88. Rifampin Value Chain Figure 89. Rifampin Production Process Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Bottom-up and Top-down Approaches for This Report Figure 93. Data Triangulation Figure 94. Key Executives Interviewed

Sanofi Wellona Pharma Mylan Shenyang Tonglian Group Fresenius Kabi Avet Pharmaceuticals Inc. Lannett Company Lupin Pharmaceutica Hikma Shuangding Pharm Wuhan Wujing Jiangsu Puhua Kesheng Chengdu Jinhua (Hongyun)